Dutch doctors demand action against hormone-disrupting substances

There is growing evidence that Bisphenol A, phtalates and other hormone-disrupting substances are harmful to human health. These substances are used in medical instruments. In an article that will be published today in the Dutch medical journal Medisch Contact, Annelies den Boer of Wemos and co-authors, two medical doctors and a toxicologist, call upon Dutch doctors to actively push for the use of safe medical instruments.

Hormone-disrupting substances, or endocrine disruptors, are a threat to public health and create sky-high costs. Currently, too little is happening in the Netherlands when it comes to tackling exposure to these harmful substances.


Up until now, the Dutch government has remained inactive – but it looks like the tide is turning. A report that was published this March by the Dutch National Institute for Public Health and the Environment (RIVM) revealed that exposure to Bisphenol A (BPA) poses a risk for the endocrine system and the developing immune system. Consequently, Minister Schippers announced she will take measures to reduce exposure to BPA, in particular in the case of unborn babies, infants and adolescents.


While the authors certainly applaud this development, they still think more action is needed. The government should also take measures to tackle exposure to other hormone-disrupting substances by prohibiting their use in medical instruments, children’s toys and packaging materials. Also, more should be invested in scientific research on safe alternatives.


Annelies den Boer (global health advocate, Wemos), Dr. Majorie van Duursen (toxicologist, Utrecht University), Dr. Gavin ten Tusscher (paediatrician, Westfriesgasthuis, Hoorn), Dr. Paul de Jong (oncologist, Antonius Hospital, Nieuwegein): ‘Help hormoonverstorende stoffen de wereld uit’, Medisch Contact 20/2016


De Volkskrant, a popular Dutch daily newspaper, published an article about this topic

Medisch Contact, a Dutch medical journal, also published a newsitem about this topic


Recent News items

The Foreign Trade and Development Cooperation policy document does not sufficiently address access to healthcare for poorer people


The new policy paper of Minister Schreinemacher of Foreign Trade and Development Cooperation, “Doen waar Nederland goed in is (“Doing what the Netherlands is good at”), is very much focused on Dutch business interests and seems to have insufficient attention for realising access to health care for poorer population groups. The Minister indicates that she wants to invest more in public-private collaborations in low- and middle-income countries, also in healthcare. As a result, there is a great risk that healthcare will become more commercial and therefore unaffordable for people with fewer financial resources. To provide good healthcare, the Minister should, instead, contribute to strengthening the capacity and financial resources in the public sector. 

Continue reading

What are best practices to address brain drain of health workers?


What are best (regional) practices when it comes to addressing brain drain – i.e. the emigration of skilled workers, including health workers – and what action is needed on EU level? With this open consultation, the European Commission is interested in feedback on the scale and dynamics of brain drain, and in successful practices and regional strategies and policies to tackle the emigration of qualified workers. Wemos has provided input to the consultation. We recommend, for example, that EU Member States use existing instruments to implement policies and strategies based on evidence, to strengthen their health workforce.

Continue reading